Paid Clinical Trials in Humble, TX
As of July 2026, 28 paid clinical trials are recruiting in Humble, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Humble offers studies at sites including Vital Heart and Vein for conditions such as Cardiovascular Disease, Obesity, Advanced Non-Small Cell Lung Cancer, Arteriovenous Fistula. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Humble
Trials by drug in Humble
Filter results
Newly added in Humble
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
27 clinical trials
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Pivotal Study of the Velocity™ pAVF System
WRAP North America
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)
Lumason® Infusion vs. Bolus Administrations
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Top Research Study Locations in Humble
Researchers run research studies in Humble, TX at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Vital Heart and Vein | Cardiovascular Disease, Obesity, Atherosclerotic Cardiovascular Disease | 8 |
| Humble Vascular Surgical Center | Arteriovenous Fistula, Chronic Kidney Disease, End Stage Renal Disease (ESRD) | 3 |
| Texas Oncology - Gulf Coast | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| Accurate Clinical Research, Inc | Non-Segmental Vitiligo (NSV), T1D, T1DM | 2 |
| Accurate Clinical Research | Cutaneous Lupus Erythematosus, Systematic Lupus Erythematosus | 1 |
| Accurate Clinical Research, Inc. | Systemic Lupus Erythematosus (SLE) | 1 |
| Anthos Investigational | Atrial Fibrillation (AF) | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Memorial Hermann Northeast Hospital | Intracranial Meningioma, NF2 Gene Mutation, Recurrent Meningioma | 1 |
| Provecta Research Path Forward Ventures | Focal Segmental Glomerulosclerosis | 1 |
| Townsen Memorial Hospital | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Humble (2026)
Recruiting trials in Humble grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (6 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions · Boston Scientific Corporation
Cancer & tumors (3 active studies)
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) · Phase 3 · Pfizer
Diabetes & metabolic (3 active studies)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Pediatric (1 active study)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Common conditions studied in Humble
- Cardiovascular Disease (3 active studies)
- Obesity (2 active studies)
- Advanced Non-Small Cell Lung Cancer (1 active study)
- Arteriovenous Fistula (1 active study)
- Atherosclerotic Cardiovascular Disease (1 active study)
- Atrial Fibrillation (AF) (1 active study)
Leading research sponsors in Humble
- Amgen
- AstraZeneca
- Pfizer
- Alliance for Clinical Trials in Oncology
- Alnylam Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Humble?
There are approximately 28 recruiting clinical trials in Humble, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Humble pay participants?
Most recruiting trials in Humble compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Humble?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Humble?
The most common conditions under active study in Humble include Cardiovascular Disease (3), Obesity (2), Advanced Non-Small Cell Lung Cancer (1), Arteriovenous Fistula (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Humble?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Humble on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Humble?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Humble?
Recruiting research sites in Humble include Vital Heart and Vein, Humble Vascular Surgical Center, Texas Oncology - Gulf Coast, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Humble right now?
The largest active categories in Humble are Cardiovascular (6), Cancer & tumors (3), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.